Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Acadia Healthcare Company Inc (ACHC.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-01-24	54.79	80.00	Buy
2022-02-28	56.71	79.00	Buy
2022-05-03	67.44	86.00	Buy
2022-06-15	65.95	82.00	Buy
2022-07-28	81.68	90.00	Buy
2022-11-01	80.25	96.00	Buy
2023-04-24	73.87	92.00	Buy
2023-07-28	79.42	88.00	Buy
2024-02-27	87.38	102.00	Buy
2024-10-31	42.69	70.00	Buy
2025-03-02	29.98	45.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.